Working to Eradicate Gynecologic Cancers

Kathryn Maurer, MD

Dr.
Cleveland Clinic
9500 Euclid Avenue
Cleveland, OH
USA 44195

Papers:
102 The impact of percent reduction in CA-125 levels on prediction of the extent of interval cytoreduction and outcome in patients with advanced stage cancer of müllerian origin treated with neoadjuvant chemotherapy